Dissolution / in vitro release testing of novel dosage forms
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: BROWN, Cynthia (Eli Lilly & Company, Indianapolis, United States of America)
In the pharmaceutical industry, dissolution testing is a very important tool in drug development and quality control. While initially developed for conventional immediate release and controlled/modified release oral dosage forms, over the past several years the application of dissolution testing has widened to a variety of 'novel' or 'special'.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.